Our range of products include comfora 100 mg capsule, samtica abiraterone 250mg tablets, taficita 200mg/25mg tablet, ibyra olaparib 100 mg tablet, laviat lenalidomide 25mg capsules and telamide temozolomide 100mg capsules.
Divy Tradelink offers an extensive selection of oral anti-cancer capsules sourced from India’s leading oncology drug manufacturers. Our anti-cancer capsule range includes targeted therapies, chemotherapy agents, and hormone-based treatments used across a wide spectrum of cancer types, including lung, breast, blood, prostate, and gastrointestinal cancers.
Oral chemotherapy and targeted cancer therapies offer patients the convenience of at-home treatment compared to hospital-administered infusions, while maintaining the same rigorous efficacy standards. Our capsule formulations include tyrosine kinase inhibitors, antimetabolites, and other mechanism-specific therapies that work by disrupting cancer cell growth, blocking abnormal protein signaling, or inducing cancer cell death.
Every product in our anti-cancer capsule category is manufactured in WHO-GMP certified facilities, with full documentation available for international export, including Certificates of Pharmaceutical Product (COPP), Free Sale Certificates, and batch-specific quality assurance reports. We supply to hospitals, oncology clinics, distributors, and pharmaceutical importers across the Middle East, Africa, Southeast Asia, and beyond.
Given the complexity and potency of oncology medications, we recommend reviewing detailed product pages for composition, mechanism of action, and safety information before placing bulk orders. Our team can also assist with sourcing specific brands or generic equivalents not currently listed, backed by competitive export pricing and reliable logistics support.
